Compile Data Set for Download or QSAR
Report error Found 7 Enz. Inhib. hit(s) with all data for entry = 8874
TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425972(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(6-fluoro-be...)
Affinity DataIC50: 51.3nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425970(5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(2-methoxyphe...)
Affinity DataIC50: 57.3nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425973(5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(6-fluoro-ben...)
Affinity DataIC50: 87.7nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425975(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(6-fluoro-be...)
Affinity DataIC50: 116nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425967(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50: 205nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425971(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50: 220nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425969(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50: 346nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent